Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Tretinoin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Multiple Myeloma 1 Leukemia, Promyelocytic, Acute 1 Leukemia 1 Hematologic Neoplasms 1 Hematologic Diseases 1

Interventions

Dexamethasone 53 daratumumab 39 Lenalidomide 32 Bortezomib 25 pomalidomide 24 carfilzomib 24 Specimen Handling 21 Biopsy 19 Magnetic Resonance Spectroscopy 17 Cyclophosphamide 14 Calcium Dobesilate 12 talquetamab 11 iberdomide 9 fludarabine 8 dexamethasone acetate 7 dexamethasone 21-phosphate 7 auricularum 7 Nivolumab 7 trametinib 5 Melphalan 5 elotuzumab 4 belantamab mafodotin 4 X-Rays 4 Sunitinib 4 Nuclear Medicine Department, Hospital 4 Ipilimumab 4 tocilizumab 3 selinexor 3 pertuzumab 3 palbociclib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06536413 2026-04-03

ATRA

The Methodist Hospital Research Institute

Phase 1/2 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡